When Should Kids Be Tested for Antithrombin Deficiency?
At a Glance
Children of parents with congenital antithrombin deficiency have a 50% chance of inheriting the condition. However, doctors generally recommend delaying testing until adolescence unless the child requires major surgery, starts estrogen-based birth control, or develops symptoms of a blood clot.
If you have congenital antithrombin deficiency, it is completely natural to worry about passing this condition to your children. The short answer to your question is: yes, your children can inherit the condition, but most medical experts recommend waiting until they are older before testing them for it [1][2]. Unless your child is having major surgery, needs hormonal birth control, or shows unusual symptoms, testing is usually delayed until adolescence or young adulthood [3][4].
Understanding the Odds: How It Is Inherited
Congenital antithrombin deficiency is an autosomal dominant genetic condition [1]. In plain language, this means that a child only needs to inherit one copy of the mutated gene (usually the SERPINC1 gene) from one parent to have the deficiency [5][6]. Because you have the condition, each of your children has exactly a 50% chance of inheriting the gene mutation [5].
Why Doctors Usually Recommend Waiting
While hearing that your child has a 50% chance of inheriting a clotting disorder is frightening, it is important to know that the baseline risk of a blood clot in childhood is incredibly small. Even with the deficiency mathematically increasing that risk compared to the general population, the overall chance of a clot in an active, healthy child remains very low [7]. Current medical guidelines generally discourage routine testing for asymptomatic children (children with no symptoms of a clot) [8][9].
Doctors recommend delaying testing for several important reasons:
- It does not change daily care: Even if a child tests positive, doctors will not put a healthy, growing child on daily blood thinners just to prevent a clot [2][10]. Since knowing the test result does not change how you raise or treat your child day-to-day, early testing is not medically necessary [2].
- Children’s blood is different: Initial testing usually involves a simple blood test to check antithrombin activity levels rather than a complex DNA test. However, newborns and infants naturally have lower antithrombin levels than adults, which usually reach adult ranges by around 6 months of age [11][12]. This can lead to confusing or false-positive results if the blood tests are done too early or not interpreted carefully [1].
- Emotional and practical impacts: Testing a young child can cause unnecessary medical anxiety for both you and your child. Furthermore, placing a genetic diagnosis on a minor’s permanent medical record could potentially create complications for them later in life when they apply for certain types of insurance, such as life or disability coverage.
When Your Child Should Be Tested
While routine testing is delayed, there are specific, high-risk situations where knowing your child’s antithrombin status becomes medically important. You should discuss testing with your child’s pediatrician if:
- They need major surgery or are immobilized: Surgery significantly increases the risk of blood clots. Preoperative testing is essential before major procedures (like orthopedic or heart surgeries) so the medical team can provide preventative blood thinners or antithrombin concentrate if needed [3][13]. Severe sports injuries that require casting or prolonged bed rest should also trigger a conversation about testing [14].
- They are approaching adolescence: Testing is highly recommended for teenagers who are considering starting hormonal therapy, such as estrogen-based birth control pills [4][15]. Estrogen increases clotting risk, so teens with antithrombin deficiency will need non-hormonal or progestin-only alternatives. This is also a critical time to warn teenagers about the extreme dangers of smoking and vaping, which heavily compound the risk of blood clots [4]. Testing is also vital before a young adult plans a pregnancy [16][4].
- They develop suspicious symptoms: If your child ever experiences unexplained swelling in an arm or leg, sudden chest pain, or shortness of breath—which are signs of a blood clot (thrombosis)—they should be evaluated and tested immediately [14].
- They have other medical conditions: If your child develops conditions that increase clotting risk, such as severe kidney issues (nephrotic syndrome) or autoimmune diseases, testing may be warranted earlier [17][18].
For now, the most empowering thing you can do is keep your child active, ensure they stay hydrated, and simply inform their doctors, dentists, or physical therapists that there is a strong family history of congenital antithrombin deficiency.
What to say to your child’s doctor:
“I have congenital antithrombin deficiency, which is an inherited clotting disorder. I know standard protocol is to delay testing children until they are older or need surgery, but I want to make sure this family history is clearly noted in their chart just in case of an emergency.”
Common questions in this guide
What are the chances my child will inherit antithrombin deficiency?
Why do doctors wait to test children for inherited blood clotting disorders?
When is early testing for antithrombin deficiency medically necessary for a child?
What symptoms of a blood clot should I watch for in my child?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.At what age do you typically recommend screening teenagers with a family history of antithrombin deficiency?
- 2.If my child breaks a bone and requires a cast, or needs minor surgery, how will we manage their potential clotting risk without knowing their test status?
- 3.What specific symptoms in my child should prompt me to bring them to the emergency room for a potential blood clot?
- 4.How can we ensure any on-call doctors, emergency teams, or dentists are immediately aware of our family history?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Management of antithrombin deficiency: an update for clinicians.
Bravo-Pérez C, Vicente V, Corral J
Expert review of hematology 2019; (12(6)):397-405 doi:10.1080/17474086.2019.1611424.
PMID: 31116611 - 2
Complications of Mesenteric Vein Thrombosis: Heterozygous Factor V Leiden Mutation Leads to Pulmonary Embolism in a Patient With Post-Bowel Resection Surgery.
Hamza HM, Malik MM, Awan AA, et al.
Clinical case reports 2025; (13(1)):e70092 doi:10.1002/ccr3.70092.
PMID: 39764273 - 3
Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency.
Nishimura Y, Takagi Y
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2018; (24(4)):187-192 doi:10.5761/atcs.oa.18-00030.
PMID: 29681597 - 4
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing.
Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, et al.
Blood advances 2023; (7(22)):7101-7138 doi:10.1182/bloodadvances.2023010177.
PMID: 37195076 - 5
Clinical Phenotype and Genetic Analysis of a Family with Hereditary Antithrombin Deficiency Caused by SERPINC1 Gene Mutation.
Zhao Y, Du L, Lin S, et al.
Thrombosis and haemostasis 2026; (126(1)):87-94 doi:10.1055/a-2558-8193.
PMID: 40097149 - 6
Genetic and clinical characterization of two families with severe venous thromboembolism due to nonsense mutations in the SERPINC1 gene.
Wei X, Chen W, Zhang J, Mao J
Thrombosis journal 2025; (23(1)):118 doi:10.1186/s12959-025-00803-y.
PMID: 41366676 - 7
Incidence and features of thrombosis in children with inherited antithrombin deficiency.
de la Morena-Barrio B, Orlando C, de la Morena-Barrio ME, et al.
Haematologica 2019; (104(12)):2512-2518 doi:10.3324/haematol.2018.210666.
PMID: 30975910 - 8
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
Méan M, Limacher A, Stalder O, et al.
The American journal of medicine 2017; (130(10)):1220.e17-1220.e22 doi:10.1016/j.amjmed.2017.05.026.
PMID: 28606797 - 9
Pneumococcal meningitis and endocarditis in an infant: possible improved survival with factor V Leiden mutation.
Mohapatra S, Doulah A, Brown E
European journal of pediatrics 2017; (176(10)):1439-1442 doi:10.1007/s00431-017-2973-1.
PMID: 28801724 - 10
Inherited Thrombophilia as a Risk Factor for Persistent Left Ventricular Thrombus Following Acute Myocardial Infarction.
Mróz K, Paszek E, Wypasek E, Undas A
Thrombosis and haemostasis 2026; doi:10.1055/a-2794-5001.
PMID: 41663081 - 11
The Effect of Direct Oral Anticoagulants on Antithrombin Activity Testing Is Abolished by DOAC-Stop in Venous Thromboembolism Patients.
Ząbczyk M, Natorska J, Kopytek M, et al.
Archives of pathology & laboratory medicine 2021; (145(1)):99-104 doi:10.5858/arpa.2020-0021-OA.
PMID: 33367661 - 12
Antithrombin III Levels and Outcomes Among Patients With Trauma.
Farrell DH, McConnell KM, Zilberman-Rudenko J, et al.
JAMA network open 2024; (7(8)):e2427786 doi:10.1001/jamanetworkopen.2024.27786.
PMID: 39145978 - 13
Congenital Antithrombin Deficiency in a Pregnant Woman with Right Atrium Thrombosis.
Sabzi F, Khosravi D, Faraji R
Ethiopian journal of health sciences 2015; (25(4)):385-9 doi:10.4314/ejhs.v25i4.15.
PMID: 26949306 - 14
Type II antithrombin deficiency caused by a novel missense mutation (p.Leu417Gln) in a Chinese family.
Liu S, Wang H, Xu Q, et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2021; (32(1)):57-63 doi:10.1097/MBC.0000000000000973.
PMID: 33196512 - 15
Thrombophilia, risk factors and prevention.
Campello E, Spiezia L, Adamo A, Simioni P
Expert review of hematology 2019; (12(3)):147-158 doi:10.1080/17474086.2019.1583555.
PMID: 30773075 - 16
Hereditary Antithrombin Deficiency in Pediatric Patients: Pathophysiology, Clinical Features, Diagnosis, and Antithrombin Replacement Therapy.
Rodgers GM, Rodriguez WI
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2026; (32()):10760296261425036 doi:10.1177/10760296261425036.
PMID: 41706600 - 17
Primary and secondary thrombophiliа: pathogenesis, clinical presentation, approaches to thrombotic complications prevention and treatment.
Bereziuk OM, Mazur JV, Berko GK, et al.
Wiadomosci lekarskie (Warsaw, Poland : 1960) 2019; (72(5 cz 1)):908-913.
PMID: 31175794 - 18
Thrombotic Diathesis Combined With Connective Tissue Disease in a Chinese Teenage Male: A Case Report.
Chen X, Song S, Zhang Z, Wang J
International journal of rheumatic diseases 2025; (28(4)):e70228 doi:10.1111/1756-185X.70228.
PMID: 40269468
This page provides educational information about pediatric testing for inherited blood clotting disorders. It is not medical advice; always consult your child's pediatrician or hematologist regarding screening and care decisions.
Get notified when new evidence is published on Hereditary thrombophilia due to congenital antithrombin deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.